Bob Doll named CEO of Crossmark

Bob Doll named CEO of Crossmark
Doll, who succeeds Mike Kern as the faith-based investment management firm's CEO, will continue to serve as its chief investment officer.
JAN 16, 2024

Bob Doll, the market strategist who’s known for his annual predictions on the markets, has been named president and chief executive of Crossmark Global Investments, a faith-based investment management firm headquartered in Houston, where he has served as chief investment officer since 2021.

Doll succeeds Mike Kern, Crossmark’s president and CEO since 2015, who is leaving to pursue other opportunities.

Doll will continue to serve as the firm's CIO in addition to being president and CEO.

“Crossmark’s clients have benefitted from Bob’s exceptional investment expertise, market perspective, and institutional leadership ever since he joined our firm, and we are excited about the vision and direction that he will bring to the organization in his expanded role as president and CEO,” Crossmark’s board said in a statement. “His investment market acumen, including his perspective as the manager of our U.S. Large Cap Equity strategies, will be valuable elements of his overall vision for our firm.”

Doll has been in the asset management industry for 44 years. Before joining Crossmark, he was chief equity strategist and senior portfolio manager at Nuveen Asset Management. Earlier, he serving as chief equity strategist at BlackRock, president and chief investment officer at Merrill Lynch Investment Managers, and chief investment officer at Oppenheimer Funds.

Latest News

Retiree alleges advisor withheld $600K through real estate LLC web
Retiree alleges advisor withheld $600K through real estate LLC web

$1.7M invested from an inheritance. Then the phone went dead.

SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception
SEC accuses Linqto chiefs of 'Wizard of Oz' investor deception

The pre-IPO platform sold $430M in units while allegedly rigging prices behind the scenes.

GLP-1 users are trading retirement savings for their prescriptions
GLP-1 users are trading retirement savings for their prescriptions

A Nationwide survey finds 47% of GLP-1 users have never discussed the drugs’ financial impact with an advisor, even as many dip into savings.

Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors
Inspired Healthcare sale price of properties is 59% of $1.2 billion sold by advisors

The hundreds of millions of dollars from a sale of Inspired Healthcare properties does not mean an immediate windfall for investors.

Class action alleges Webull misled investors about China operations
Class action alleges Webull misled investors about China operations

Its SEC filings said one thing - a congressional probe said another.

SPONSORED Built on insurance experience to deliver on long-term promises

Knighthead Life entered the market with a competitive MYGA. A strong launch earned advisor confidence and paved the way for FIAs.

SPONSORED In the Age of AI, Trust Becomes the Advisor's Greatest Asset

As AI makes financial information more accessible than ever, Lana Hock explains why human judgment, trust, and empathy remain the qualities clients value most in a financial advisor